Barclays Maintains an 'Equalweight' on Onyx Pharmaceuticals (ONXX); Facing Uphill Battle
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Price: $124.70 --0%
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Onyx Pharmaceuticals (NASDAQ: ONXX) price target raised from $40 to $44.
Analyst, Ying Huang, said, "We continue to believe carfilzomib will face an uphill battle for accelerated approval. Carfilzomib has an upcoming Oncologic Drugs Advisory Committee (ODAC) panel on June 20th, and PDUFA date of July 27th. Based on historical precedent, we believe FDA approval with a single arm Phase II study under standard review is unlikely."
Huang slashes FY12 EPS loss from -1.06 to -2.73 and FY13 from -1.30 to -2.83.
Note - currently shares are trading down $2.26 (-5.02%), which is near the session low.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $45.00 yesterday.
Analyst, Ying Huang, said, "We continue to believe carfilzomib will face an uphill battle for accelerated approval. Carfilzomib has an upcoming Oncologic Drugs Advisory Committee (ODAC) panel on June 20th, and PDUFA date of July 27th. Based on historical precedent, we believe FDA approval with a single arm Phase II study under standard review is unlikely."
Huang slashes FY12 EPS loss from -1.06 to -2.73 and FY13 from -1.30 to -2.83.
Note - currently shares are trading down $2.26 (-5.02%), which is near the session low.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $45.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
